Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu nasal spray, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback